Glaxo Smith Kline News - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
15 April 02:57 AM

Glaxo Smith Kline (BIOC)

Last update: 14 April 02:27 PM market time.
65.11
0.36
0.56%
Open 64.75
Previous Close 64.75
High 66.97
Low 65.00
Stock Statistics
Volume 129,828
Turnover 8,568,501.00
All data are 15 minutes late during market session

News

The majority shareholder is currently not willing to sell its stake in the company.
15 March 2021 11:04 AM GSK Egypt rejects due diligence request from ACDIMA
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) has rejected a request from the Arab Company for Drug Industries & Medical Appliances (ACDIMA) to conduct due diligence on the company, according to a bourse disclosure on …
Corporate Actions
The majority shareholder is not currently willing to sell any of its shares in the company
14 March 2021 00:11 PM Galxo Group rejects offer to sell shares in GSK Egypt
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) has received a letter from the Arab Company for Drug Industries & Medical Appliances (ACDIMA) expressing its interest to acquire the majority shareholder’s stake in the company. ACDIMA requested to be …
Mergers and Acquisitions
Galxo Group Limited decided to focus on talks with Hikma Pharmaceuticals
9 February 2021 01:27 PM Rameda retracts offer to acquire GSK Egypt
Cairo – Mubasher: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) retracted its offer to acquire the shares of Galxo Group Limited in Glaxo SmithKline (GSK Egypt), according to a bourse disclosure on Tuesday. This …
Mergers and Acquisitions
Glaxo Group Limited considers to sell its entire stake of 91.2% in GSK Egypt
8 February 2021 04:36 PM Galxo Group rejects talks with Rameda, ACDIMA over potential acquisition
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) said that its majority shareholder, Galxo Group Limited, responded to the letters of Arab Company for Drug Industries & Medical Appliances (ACDIMA) and the Tenth of Ramadan for Pharmaceutical …
Mergers and Acquisitions
Galxo Group owns a 91.2% stake in GSK Egypt.
1 February 2021 00:17 PM ACDIMA expresses interest to buy majority stake in GSK Egypt
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) said that its majority shareholder, Galxo Group Limited, received a letter from the Arab Company for Drug Industries & Medical Appliances (ACDIMA) expressing its interest to submit an offer to acquire …
Mergers and Acquisitions
Hikma Pharmaceuticals signed non-binding deal to acquire GSK Egypt
27 January 2021 00:20 PM Hikma Pharmaceuticals allowed to conduct due diligence on GSK Egypt
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) agreed to allow Hikma Pharmaceuticals Plc to conduct due diligence on the company, according to a bourse disclosure on Wednesday. On Tuesday, the company said that its …
Mergers and Acquisitions
GSK Egypt reported net profits of EGP 101.41 million in nine months
26 January 2021 01:57 PM Hikma Pharmaceuticals to acquire majority stake in GSK Egypt
Cairo – Mubasher: Galxo Group Limited signed a non-binding term sheet with Hikma Pharmaceuticals Plc for the potential sale of its entire stake of 91.2% in Glaxo SmithKline (GSK Egypt). The acquisition will be implemented by submitting a mandatory …
Mergers and Acquisitions
GSK Egypt reported net profits of EGP 101.41 million in nine months
24 December 2020 00:43 PM GSK Egypt considers merge of Amoun Pharmaceutical Industries
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) decided to form a committee to study the merge of Amoun Pharmaceutical Industries into the company. The board also approved to refer the decision of the appointment of …
Mergers and Acquisitions
GSK Egypt reported net profits of EGP 101.41 million in nine months
1 December 2020 01:31 PM GSK Egypt responds to reports about Amoun Pharma acquisition
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) responded to news reports about the acquisition of its subsidiary Amoun Pharmaceutical Industries. GSK Egypt said that it is not the source of these news reports, according to a bourse disclosure on …
Mergers and Acquisitions
sales increased to EGP 1.42 billion in the January-September period
11 November 2020 03:39 PM GSK Egypt's profit surges 51% in 9M
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) reported a 51.2% year-on-year (YoY) growth in its consolidated net profits, logging EGP 101.41 million in the first nine months of 2020, compared to EGP 67.03 million. The company’s sales increased to …
Financial Results
Kahira Pharmaceuticals jumped by 32% in three months
20 October 2020 05:09 PM Pharma stocks lead EGX ahead of potential acquisitions
Cairo – Mubasher: Amid market volatility due to concerns over a second wave of coronavirus (COVID-19) infections, pharmaceutical stocks on the Egyptian Exchange (EGX) reported strong performance ahead of potential mergers and acquisitions. Amr …
Trading Activities
The company’s net sales increased to EGP 941.76 million
16 August 2020 05:46 PM GSK Egypt sees four-fold profit rise in H1-20
Cairo – Mubasher: The consolidated financial statements of Glaxo SmithKline (GSK Egypt) showed net profits of EGP 115.96 million in the first half (H1) of 2020, a 302% year-on-year (YoY) increase from EGP 28.847 million. The company’s net sales …
Financial Results
The pharmaceutical company’s net sales increased to EGP 433.97 million
6 July 2020 00:25 PM GSK Egypt turns profitable in Q1-20
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) turned to net profits of EGP 33.14 million during the first quarter (Q1) of 2020, against net losses of 7.55 million in the year-ago period, including minority shareholders’ rights, the consolidated …
Financial Results
The company’s total investments in Egypt reached $800 million
21 November 2019 00:40 PM GSK Egypt to launch 2 production lines with EGP 100m investments
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) announced plans to inaugurate two production lines with investments worth EGP 100 million.  The company will open a new line for producing Voltaren with investments amounting to EGP 20 million during …
Companies Investments
Total investments of GSK Egypt amounted to $800 million
10 November 2019 01:51 PM GSK Egypt to launch 3 new production lines in 2 yrs
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) aims to launch three new production lines valued at EGP 180 million in 2019 and 2020, the company’s general manager Amr Mamdouh said. GSK Egypt’s new investments include EGP 100 million for opening …
Ministries
Q1 losses tumbled to EGP 7.55 million
29 October 2019 00:44 PM GSK Egypt turns to EGP 7.6m loss in Q1-19
Cairo – Mubasher: The consolidated financial statements of Glaxo SmithKline (GSK Egypt) showed a year-on-year turn to losses during the first quarter of 2019. The losses amounted to EGP 7.55 million in Q1-19, against profits of EGP 22.07 million …
Company News
Revenues increased to EGP 1.62 billion
26 September 2019 01:05 PM GSK Egypt’s profit drops 57% in 2018
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) reported a 56.6% year-on-year profit decrease during 2018. Net profits plunged to EGP 49.92 million during the twelve-month period ended 31 December, compared to EGP 115.18 million in 2017, the …
Financial Results
Net sales hiked to EGP 1.13 billion
19 September 2019 02:55 PM GSK Egypt's profit slides 45% in 9M
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) reported a 44.9% year-on-year profit drop during the first nine months of 2018, the company’s consolidated financial statements showed. Net profits plunged to EGP 129.53 million from January to …
Financial Results
Trading will be halted until the companies disclose their financial results
7 July 2019 02:22 PM EGX continues trading suspension on three stocks
Cairo – Mubahser: The Egyptian Exchange (EGX) announced that it will continue to halt trading on the stocks of Golden Pyramids Plaza, Middle East Glass Manufacturing Company (MEG), and Glaxo SmithKline (GSK Egypt) as the three companies have not …
Corporate Actions
Net profit amounted to EGP 60.16 million in the nine-month period ended September
27 November 2018 02:43 PM GSK Egypt profit drops 42% in 9M
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) on Tuesday posted a 42% year-on-year decline in its consolidated profits for the first nine months of 2018. Net profit amounted to EGP 60.16 million in the nine-month period ended September, compared …
Financial Results
The company’s sales grew to EGP 661.68 million in the period from January to June
14 December 2017 00:26 PM Glaxo SmithKline – Egypt posts consolidated profits in H1
Cairo – Mubasher: Glaxo SmithKline – Egypt on Thursday reported turning a profit in its consolidated results in the first half of 2017 on the back of higher sales. The pharmaceutical company achieved EGP 103.86 million in consolidated profits in …
Financial Results
Companies include Beltone, Glaxo SmithKline, Arab Polvara, and Nile City Investment
7 June 2017 03:45 PM EGX give companies 15 days to reveal financials
Cairo - Mubasher: The Egyptian Exchange (EGX) listing committee has decided to allow 10 companies a 15-day grace period to present their financial statements, approved by their respective ordinary general meeting (OGM). The situation will be …
Management Decisions
Egypt’s Glaxo SmithKline launches new production line
8 November 2016 04:25 PM Egypt’s Glaxo SmithKline launches new production line
Cairo – Mubasher: Glaxo SmithKline – Egypt launched a new production line worth EGP 60 million, said Minister of Investment Dalia Khorshid. The new production line capacity is up to 30 million units annually and comes in the framework of the …
Companies Investments
The cash dividend payout represents 5% of the paid-in capital - Photo Credit: Reuters
8 September 2016 00:13 PM Glaxo SmithKline shareholders nod for EGP 0.5/shr dividends
Cairo – Mubasher: Glaxo SmithKline announced Thursday that its ordinary general meeting approved distributing cash dividends for the fiscal year 2015 at EGP 0.5 a share, according to a bourse filing. The cash dividend payout represents 5% of the …
Cash Dividends
pharmaceuticals
23 August 2016 02:07 PM Glaxo SmithKline turns to losses in Q2
Cairo – Mubasher: Glaxo SmithKline turned to losses in the second quarter of 2016, as it logged losses of EGP 38.3 million ($4.3 million). The drug company posted losses of EGP 26.7 million ($3.01 million) for the same period of the previous year. …
Financial Results